Global Immune Checkpoint Inhibitors Market 2019-2023
About this market
The growing number of cancer cases being diagnosed across the globe. Various international and national level campaigns are conducted to increase the awareness about cancer and to help early detection of the disease. Technavio’s analysts have predicted that the immune checkpoint inhibitors market will register a CAGR of almost 3% by 2023.
High target affinity and specificity of immune checkpoint inhibitors drugs
Most of the approved therapies for cancer treatment have severe side effects, which lowers the patient compliance towards the treatment. Thus, these drawbacks help the immune checkpoint inhibitors market grow.
High costs associated with the treatment
Treatment cost is one of the major challenges for cancer patients. The high cost is mainly due to hospitalization, laboratory costs, and novel immunotherapies.
For the detailed list of factors that will drive and challenge the growth of the immune checkpoint inhibitors market during the 2019-2023, view our report.
The market appears to be fragmented and with the presence of several companies including AstraZeneca and Bristol-Myers Squibb the competitive environment is quite intense. Factors such as the high target affinity and specificity of immune checkpoint inhibitors drugs and the growing number of cancer cases being diagnosed across the globe will provide considerable growth opportunities to immune checkpoint inhibitors manufactures. AstraZeneca, Bristol-Myers Squibb, Merck Sharp & Dohme, Pfizer, and F. Hoffmann-La Roche are some of the major companies covered in this report.
‘With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.’
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook